InspireMD launches massive cardiac stent trial; RIP Barnaby Jack;

@FierceMedDev: Check out last week's special report: Top 10 Med Tech Investments of Q2. Report | Follow @FierceMedDev

@MarkHFierce: ReVision optics closed $55M in new equity financing. Medical Device financing shows some signs of life. Release | Follow @MarkHFierce

@DamianFierce: Quintiles has signed up to help Ascendancy Healthcare cash in on the Chinese pharma boom. More | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. Item | Follow @MichaelGFierce

> Telegraph Hill Partners said it has raised a $310 million fund focused exclusively on life science and healthcare investing. Item

> Computer hacker and expert Barnaby Jack, who helped expose a security flaw in insulin pumps, has died unexpectedly at the age of 36. Story

> Drug-eluting stents help protect heart attack patients from developing bleeding complications, a new study in the U.S. and Germany has determined. Item

> InspireMD has enrolled its first patient in an IDE clinical trial testing the safety and effectiveness of its MGuard Prime embolic protection stent in patients with a certain type of heart attack. More than 1,000 patients will eventually take part. Item

> Cook Medical will rely on a hospital in Bloomington, IN, to help test a potential new stent treatment for peripheral artery disease. Item

> Carroll Neubauer, chairman and CEO of B. Braun Medical, is the latest executive to publicly push for the repeal of the 2.3% medical device industry tax. Item

> Mercator MedSystems now has a patent meant to secure the U.S. rights to use its Micro-Infusion drug delivery platform for renal denervation or carotid body modulation procedures. Item

> BioLineRx wants to launch a CE mark registration trial for a pen/liquid device that enables the non-surgical removal of skin lesions. Item

Biotech News

@FierceBiotech: ICYMI: Scripps spinout aTyr grabs $59M in venture deals with a public twist. Story | Follow @FierceBiotech

@RyanMFierce: Add Five Prime to the biotech IPO queue, hunting for $60M public debut with backers from Pfizer, GlaxoSmithKline. Report | Follow @RyanMFierce

@EmilyMFierce: FDA notes 'technical deficiencies' in Chelsea's drug filing. Article | Follow @EmilyMFierce

> Scripps spinout aTyr grabs $59M in venture deals with a public twist. More

> Perrigo to take over Elan for $8.6B. Report

> Celgene spends $100M for option to buy myeloma drug developer Acetylon. News

Pharma News

@FiercePharma: Pfizer to split operations three ways. Story | Follow @FiercePharma

@EricPFierce: EU doesn't like smell of Germany's exemption to financially struggling drugmakers from paying drug rebates. More | Follow @EricPFierce

@CarlyHFierce: 's former head of China biz will be returning to China to assist with bribery probe. 18 more reportedly detained there. | Follow @CarlyHFierce

> Valeant to fire thousands, restructure ops after Bausch buyout. Report

> U.S. court upturns Teva's patents on cash-cow Copaxone. News

> OTC specialist Perrigo nabs Elan and its tax rate for $8.6B. Article

CRO News

> Swiss CRO Psi reaches into South Africa. Item

> Quintiles teams up with Ascendancy in China. News

> Icon ticks up guidance as revenue leaps another 21%. Report

> CRA buys Comprehensive Clinical's late-phase biz. Article

> AMRI working to get out from under FDA warning. More

Biotech IT News

> Medidata shares soar on another record quarter in Q2. Item

> AstraZeneca adds software from Dotmatics to virtual neuroscience group. Article

> Novo Nordisk among latest to join pharma flock on Twitter. Story

> Sanofi returns to the crowdsourcing well for diabetes app. More

> NIH earmarks $96M for multiyear effort to maximize value of Big Data. Report